Pico IV

PicoIV™ represents a groundbreaking innovation in the wellness industry, as it introduces the world’s first and only sterile CBD product specifically designed for intravenous (IV) infusion. Unlike traditional methods of CBD consumption such as oral supplements, oils, or topical applications, PicoIV™ offers a new approach that allows for increased bioavailability through IV administration. This means that the CBD extract is delivered directly into the bloodstream, bypassing the digestive system, which typically results in higher absorption rates. Users can expect maximum efficacy from the CBD, promoting overall well-being and faster recovery from physical activity.

One of the standout benefits of PicoIV™ is its focus on safety and transparency. As an IV product, it has undergone rigorous testing for purity and potency by third-party laboratories. The company has also pioneered patent-pending technology that allows them to break down CBD particles to a size small enough to pass through a sterile filter, ensuring the product’s sterility and safety for IV infusion. This technological advancement overcomes one of the biggest challenges in CBD formulation: creating a sterile, stable, and highly absorbable product that can be used intravenously.

Cannabidiol (CBD), a compound derived from the hemp plant, has been widely studied for its potential benefits, such as promoting relaxation, supporting a sense of calm, and aiding recovery from physical exertion. While the understanding of CBD’s full spectrum of health benefits is still evolving, PicoIV™ takes this research a step further by offering a next-generation, intravenous CBD option. This cutting-edge product is particularly attractive to both consumers and healthcare providers. Users can explore a new, efficient path to wellness, while healthcare professionals can integrate this novel, research-supported solution into their practice, elevating patient care.

PicoIV™ stands out in the market by combining innovation, safety, and efficacy. With its sterile CBD infusion, it offers a future-oriented wellness solution that could potentially revolutionize the way CBD is consumed, making it accessible in its most potent form through IV therapy. By increasing the bioavailability and ensuring the safety of the product, PicoIV™ empowers users to unlock the full potential of CBD, contributing to a healthier and more balanced lifestyle. However, it is important to note that these statements have not been evaluated by the FDA, and the product is not intended to diagnose, treat, or cure any disease.